
European Journal of Medicinal Chemistry p. 423 - 436 (1998)
Update date:2022-08-05
Topics: Synthesis Inhibitors Catalyst Purification Reaction Conditions Activity Biological assay HIV protease
Garrouste, Patrick
Pawlowski, Macek
Tonnaire, Thierry
Sicsic, Sames
Dumy, Pascal
De Rosny, Eve
Reboud-Ravaux, Michele
Fulcrand, Pierre
Martinez, Jean
We report here the synthesis and activity of HIV protease inhibitors. In the first stage hydrophobic compounds incorporating a 'carba' bond surrogate or a beta-homologated residue were synthesized. Secondly, we synthesized cyclic compounds in which we incorporated 2-quinoline carboxylic acid in the P3 position and the amino-hydroxyindane moiety in the P'3. The last part of this work was dedicated to a structure/activity study of a peptide substrate. These modifications allowed us to work up the synthesis of new pseudopeptide bonds: amino-amide and hydroxy-amide. Compounds with activity in the micromolar range were actually a starting point for the synthesis of new protease inhibitors.
View MoreZhejiang Sucon Silicone Co.,Ltd
Contact:+86-575-88046692
Address:Qisheng Rd., Paojiang Industrial Zone, Shaoxing, Zhejiang, China.
Binzhou Holly Pharmaceutical Co.,Ltd.
Contact:74517
Address:No.15 Dapu Road,Huangpu District Shanghai,P.R.China
Contact:0572-2722882
Address:1201,F3,xinghuibandao,
Chemsky(shanghai)International Co.,Ltd.
Contact:0
Address:0
Zhejiang Golden-Shell Pharmaceutical Co.,Ltd.
Contact:+86-576-87501888 / 87501988
Address:No.89 Zhongxing Road. Li'ao, Yuhuan, Zhejiang, China
Doi:10.1016/j.ejmech.2018.11.060
(2019)Doi:10.1007/BF02232534
(1970)Doi:10.1021/jm030003x
(2003)Doi:10.1016/S0014-827X(01)01134-X
(2001)Doi:10.1107/S2053229617012761
(2017)Doi:10.1021/jo990055n
(1999)